Inari Medical, Inc.
Industry
- Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
- Minimally or Less Invasive
- Digital Health
- Disease Management
Other Names/Subsidiaries
- LimFlow
Latest on Inari Medical, Inc.
Biopharma merger and acquisition value for the first quarter of 2025 reached $38.4bn from 41 transactions, 22 of which had disclosed values. Making up almost 38% of that total was Johnson & Johnso
Inari Medical plans to pay up to $415m for Paris-based LimFlow SA to add the LimFlow transcatheter deep-vein arterialization system to its portfolio of peripheral vascular interventional devices, t
Hancock Jaffe is changing its name to enVVeno Medical Corporation to reflect its prioritization of technologies for treating venous disease. The name change will take effect on 1 October when the com
Third-quarter device financing activity reached $3.3bn, a significant drop from Q2’s $9.5bn, although 45% of the Q2 dollars can be attributed to two billion-dollar plus transactions: Stryker Corporat